Get Unlimited Plan at 75% OFF!
Blue Jet Healthcare
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968. The name of Company changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai. Subsequently, Company converted into a Public Limited and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022.
The Company a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products toward innovator pharmaceutical companies and multi-national generic pharmaceutical companies. It has operations organized into three product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). It is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare products.
Since incorporation in 1968, the Company was established with the name Jet Chemicals Private Limited' in Shahad (Unit I) by Late Shri B L Arora. It set up a contract development and manufacturing organization (CDMO) business model with specialized chemistry capabilities in contrast media intermediates and high intensity.
In 1970, the Company began manufacturing saccharin and its salts, which are high-intensity sweeteners. In 2000, it entered the X-ray contrast media sector, with a basic building block (5- NIPA). In 2002, it started manufacturing of pharma intermediates and API. In 2003, it established Blue Circle Organics Private Limited at their Unit-II, Ambernath facility. In 2017, it started semi-automated manufacturing block for their contrast media intermediate business.
The National Company Law Tribunal at Mumbai (NCLT), by way of its Order dated November 19, 2020, sanctioned a Scheme of Merger amongst the Company (Transferee Company), Blue Circle Organics Private Limited (Transferor Company) and their respective shareholders, and creditors with appointed date being April 1, 2019 and effective date being December 28, 2020. The Scheme was undertaken to form Blue Jet Healthcare Private Limited t and pursuant to this Scheme, the Transferee Company acquired the Transferor Company business as a going concern, which was vested into the interests of the Transferor Company.
In 2020 it acquired a Unit III brownfield site in Mahad.
In 2021, it acquired a Unit IV 'greenfield' manufacturing site in Ambernath.
The Company is planning to raise capital from Public by issuing 21,683,178 Equity Shares through Offer for Sale.
Blue Jet Healthcare share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Blue Jet Healthcare indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Blue Jet Healthcare is valued compared to its competitors.
Blue Jet Healthcare PE ratio helps investors understand what is the market value of each stock compared to Blue Jet Healthcare 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Blue Jet Healthcare evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Blue Jet Healthcare generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Blue Jet Healthcare in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Blue Jet Healthcare shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Blue Jet Healthcare compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Blue Jet Healthcare over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Blue Jet Healthcare helps investors get an insight into when they can enter or exit the stock. Key components of Blue Jet Healthcare Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Blue Jet Healthcare shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Blue Jet Healthcare ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Blue Jet Healthcare provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Blue Jet Healthcare highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Blue Jet Healthcare .
The balance sheet presents a snapshot of Blue Jet Healthcare ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App